Navigation Links
Muhammad Ali Parkinson Center's Youngest Patient Praises New "Sci-Fi" Procedure
Date:7/12/2013

PHOENIX, July 12, 2013 /PRNewswire/ -- First experiencing symptoms at just 29-years-old and diagnosed with Parkinson's at age 34, Tommy Zuleger is the youngest patient ever treated at the Muhammad Ali Parkinson Center at Barrow Neurological Institute in Phoenix and he says a new "sci-fi" procedure has given him his life back.

(Photo: http://photos.prnewswire.com/prnh/20130712/LA46804)

The real estate executive recently underwent a new procedure at Barrow called Asleep Deep Brain Stimulation (DBS), which involves surgically implanting a medical device, called a "brain pacemaker," while the patient is under general anesthesia. In select brain regions, DBS has provided remarkable therapeutic benefits for otherwise treatment-resistant movement disorders such as Parkinson's disease, tremor and dystonia.

"At first it was nothing major; my right hand would shake," recalls Zuleger, now 38. "But over time the shaking grew worse, I started to feel stiffer than a thirty-something. At thirty-four-years-old, I learned I had Parkinson's."

Parkinson's disease is generally thought of as a disease affecting the elderly, but the National Parkinson Foundation reports more people are being diagnosed with the disease at a younger age. Approximately 10 percent of the one million people living with the disease in the United States are under the age of 40.

Zuleger says he was initially in shock. "I wasn't upset that I had Parkinson's. I was upset because I had it and there wasn't a thing I could do to stop it," he adds.

Though Zuleger had heard of DBS, he explains that at first it wasn't something he seriously considered as an option. "Brain surgery was too scary, especially if I had to be awake while they did it."

By 2012, Zuleger's symptoms had begun to worsen. Fortunately, surgical technology at Barrow had also advanced in that time which allowed his neurologist at the Ali center, Arshia Sadreddin, MD, to recommend a new treatment option—Asleep DBS.

"This new asleep procedure allows us to approach a larger group of patients who would have previously declined the treatment," says Dr. Sadreddin. "It is a real breakthrough for those who are anxious about having awake brain surgery, and for patients like Tommy who are young, healthy and have lesser chance of side effects from general anesthesia."

While DBS has been around for a number of years, the surgeons at Barrow have taken it to a new level by allowing patients to "sleep" during the procedure. Today Barrow surgeons are performing more DBS procedures than at any hospital in the nation and Barrow is one of only a handful of institutions to offer the "asleep" procedure.

Last year, Zuleger began to prepare for the surgery as a patient in the Ali center's new DBS Clinic. "After doing a lot of research, it didn't sound as scary, and actually began to look more and more promising."

Zuleger had the surgery last October and is now back to work and loving life with his wife and four children. "My whole world changed. It was like someone was flipping a switch on in my brain. I know that DBS isn't a cure, but I feel better than I have in years and I hope that it will help to control my symptoms for years to come."

Dr. Sadreddin emphasizes that there is still no cure for Parkinson's disease and DBS is not an effective treatment for all patients. She adds, however, that this new procedure can allow more patients the opportunity to benefit from an improved quality of life they would not have enjoyed previously on medication alone.

About Barrow Neurological Institute
Home to the Muhammad Ali Parkinson Center, Barrow Neurological Institute at St. Joseph's Hospital and Medical Center in Phoenix, Arizona is an internationally renowned medical center that offers care for people from throughout the world with brain and spine diseases, disorders and injuries. U.S. News & World Report routinely lists St. Joseph's as one of the top hospitals in the nation for neurological and neurosurgical care.


'/>"/>
SOURCE St. Joseph's Hospital and Medical Center
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Deep Brain Stimulation Clinic Expedites Patient Treatment at Muhammad Ali Parkinson Center
2. Promising Parkinsons Disease Research Highlighted by The Michael J. Fox Foundation to Accelerate Drug Development
3. NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinsons Disease
4. Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinsons Disease
5. From Autism to Diabetes to Parkinsons Disease: Pew Funds 22 Early-Career Scientists to Take Calculated Risks
6. NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 International Congress of Parkinsons Disease and Movement Disorders
7. Adamas Pharmaceuticals To Report Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia In Parkinsons Disease
8. NeuroDerm Awarded $1M by The Michael J. Fox Foundation for the Clinical Development of ND0612 for Parkinsons Disease
9. Ceregene Reports Additional Efficacy Data From Parkinsons Disease Phase 2b Study
10. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
11. Dont Get Sacked by Parkinsons - Know the Full Range of Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 2017 Research and Markets has announced ... (Thermometers - Digital, Infrared, Mercury; Trend Indicator):Analysis By Region, By Country ... ... forecasted to grow at a CAGR of 5.33% during 2016-2021 ... infectious diseases along with surging demand of digital thermometer. Apart from ...
(Date:2/22/2017)... Feb. 22, 2017 Oncternal Therapeutics, Inc., ... both rare and common malignancies, today announced the ... The company intends to use the proceeds to ... and to advance preclinical development of a new ... is a first-in-class anti-ROR1 monoclonal antibody being developed ...
(Date:2/22/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced that KCP-400 (RgIA4), a potent antagonist ... robust chronic pain relief and disease modifying effects ... the a9a10 nAChR as a new, non-opioid target ... were reported online in the February 20 th ...
Breaking Medicine Technology:
(Date:2/22/2017)... , ... February 22, 2017 , ... A product of ... seem to derive a heart-protective benefit from eating soy foods, while others do not, ... men who are able to produce equol—a substance made by some types of “good” ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent ... those report that family members or friends have also commented about their poor ... loss wear hearing aids. One reason, suggested by 89 percent of American respondents, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Super-Sod will attend ... 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home Show ... , For the booth, grass seed plant manager Chris Roquemore constructed furniture from recycled ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Social media ... especially for hospitals and health systems. Smith & Jones’ delves into this insight and ... episode, President of Smith & Jones David Vener meets up with social media strategist ...
(Date:2/22/2017)... ... February 22, 2017 , ... BrightStar Care Charleston , a ... Medical University of South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, ... on Aging is a tremendous resource in our community. We are thrilled to participate ...
Breaking Medicine News(10 mins):